Back to Authors

Brockman, Jane Michelle

A5023208899

Mayo Clinic

Genentech--BioOnc, Dayton, OH;

Citations 1

Phase II trial of atezolizumab before and after definitive chemoradiation for unresectable stage III NSCLC.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS8585-TPS8585

10.1200/jco.2018.36.15_suppl.tps8585